Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page displays a new Revision: v3.6.3 tag, replacing the previous Revision: v3.6.0, signaling an update to the page or its underlying software.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now indicates that recruitment has ended and adds user-help sections to assist reading and joining the study. Formatting and revision labels were updated to reflect the new structure (Intervention/Treatment) and the latest revision version (v3.6.0).SummaryDifference0.4%

- Check32 days agoChange DetectedRevision: v3.5.5 is now displayed, replacing v3.5.4, signaling an updated entry. This appears to be a metadata revision rather than substantive changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label on the page was updated from v3.5.3 to v3.5.4. This represents a new version of the page content or documentation for the study record.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3”.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.